The potential anticancer activity of STAT, STATB, and their analogues was evaluated based on the proliferative capacity of HCT116 and T24 cells, which are well established in vitro models of human colon and bladder cancer, using the MTT assay. This evidence concerns the gene SOAT1 and urinary bladder cancer.